A new Zika virus vaccine developed in Brazil by researchers at the Institute of Tropical Medicine of the University of São Paulo's Medical School (IMT-FM-USP) has been shown to be safe and effective ...

US health authorities Wednesday launched the second human trial of a vaccine against the mosquito-borne Zika virus, which can cause birth defects and is now spreading in the US and Latin America. The ...

Three different experimental Zika vaccines being developed in the United States have worked well in monkey studies, paving the way for human trials in the coming months, researchers said Thursday. The ...

Two vaccines against Zika virus developed at the University of Pittsburgh School of Medicine have successfully conveyed immunity from female mice to pups conceived weeks after the mother's vaccination ...

Three experimental Zika vaccines protected monkeys against infection from the virus, an encouraging sign as research moves into studies in people. The success in monkeys, which involved a traditional ...

As Zika cases continue to rise around the world — and in the United States — with associated increases in Guillain-Barre syndrome and congenital birth defects, the need for a safe and effective ...

Vaccine developers have successfully protected mice against Zika by injecting synthetic messenger RNA that encodes for virus proteins into the animals. The cells of the mice then build parts of the ...

Two mouse models of Zika virus infection in pregnancy have been developed by a team of researchers at Washington University School of Medicine in St. Louis. In them, the virus migrated from the ...

Zika virus was first identified in Uganda in 1947 in a Rhesus macaque monkey. Sporadic human infections were detected across Africa and Asia from the 1960s to the 1980s. Since 2007 outbreaks of Zika ...

The vaccine is being developed by researchers at the University of São Paulo and is based on technology known as “virus-like particles” (VLPs), which does not use genetic material from the pathogen.